The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man

Experimental Eye Research

Volumn 64, Issue 3, 1997, Pages 305-312

  Schmetterer, Leopold ^a   Krejcy, Kurt ^a,b   Kastner, Johannes ^a   Wolzt, Michael ^a   Gouya, Ghazaleh ^a   Findl, Oliver ^a   Lexer, Franz ^a   Breiteneder, Helene ^a   Fercher, Adolf Friedrich ^a   Eichler, Hans Georg ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Choroidal circulation; Fundus pulsations; Human; Nitric oxide

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ARTICLE; BLOOD PRESSURE; CHOROID VASCULARIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; OPHTHALMIC ARTERY; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL;

EID: 0031105324     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0213     Document Type: Article

References (35)

1. Aisaka, K., Gross, S. S., Griffith, O. W. and Lewi, R. (1989). N-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig. Biochem. Biophys. Res. Commun. 160, 881-6.
2. Bill, A. (1975). Blood circulation and fluid dynamics in the eye. Physiol. Rev. 55, 383-417.
3. Coates, A. J. S. (1990). Doppler ultrasonic measurement of cardiac output: reproducibility and validation. Eur. Heart J. 11 Supplement I, 49-61.
4. Deussen, A., Sonntag, M., Vogel, R. (1993). L-arginine derived nitric oxide: A major determinant of uveal blood flow. Exp. Eye Res. 57, 129-34.
5. Donati, G., Pournaras, C. J., Munoz, J. L. and Tsacopoulos, M. (1994). Role du monoxide d'azote dans la regulation de la vasomotricite retinienne. Klin Mbl Augenhlk. 204, 424-6.
6. Gardiner, S. M., Compton, A. M., Bennet, T., Palmer, R. M. J. and Moncada, S. (1990). Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15, 486-92.
7. Guthoff, R. E., Berger, R. W., Winkler, P., Helmke, K. and Chumbley, L. C. (1991). Doppler ultrasonography of the ophthalmic and central retinal vessels. Arch. Ophthalmol. 109, 532-6.
8. Haefliger, I. O., Flammer, J. and Lüscher, T. F. (1992). Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 33, 2340-3.
9. Haefliger, I. O., Meyer, P., Flammer, J. and Lüscher, T. F. (1994). The vascular endothelium as a regulator of the ocular circulation: A new concept in ophthalmology? Surv. Ophthalmol. 39, 123-32.
10. Harris, A., Williamson, T. H., Martin, B., Shoemaker, J. A., Sergott, R. C., Spaeth, G. L. and Katz, J. L. (1995). Test/Retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J. Glaucoma. 4, 281-6.
11. Haynes, W. G., Noon, J. P., Walker, B. R. and Webb, D. J. (1993). L-NMMA increases blood pressure in man. Lancet 342, 931-2.
12. Iadecola, C., Pelligrino, D. A., Moskowitz, M. A. and Lassen, N. A. (1994). Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14, 175-92.
13. Jilma, B., Kastner, J., Mensik, C., Hildebrand, J., Vondrovec, B., Krejcy, K., Wagner, O. and Eichler, H. G. (1996). Sex differences in nitric oxide production. Life Sci. 58, 469-76.
14. Kharitonov, S. A., Yates, D., Robbins, R. A., Logan-Sinclair, R., Shinebourne, E. A. and Barnes, P. J. (1994). Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343, 133-5.
15. Kharitonov, S. A., Lubec, G., Lubec, B., Hjelm, M. and Barnes, P. J. (1995). L-arginine increases exhaled nitric oxide in normal human subjects. Clin. Sci. 88, 135-9.
16. Kontos, H. A. (1989). Validity of vertebral arterial blood flow calculations from velocity measurements. Stroke 20, 1-3.
17. Krejcy, K., Schmetterer, L., Kastner, J., Nieszpaur-Los, M., Monitzer, B., Schütz, W., Eichler, H. G. and Kyrie, P. (1995). Role of nitric oxide in hemostatic system activation in vivo in humans. Arteriosder. Thromb. Vasc. Biol. 15, 2063-7.
18. Langham, M. E., Farrell, R. A., O'Brien, V., Silver, D. M. and Schilder, P. (1989). Blood flow in the human eye. Acta Ophthalmol. S191, 9-13.
19. Lieb, W. E., Cohen, Merton, D. A., Shields, J. A., Mitchell, D. G. and Goldberg, B. B. (1991). Color Doppler imaging of the eye and the orbit. Arch. Ophthalmol. 109, 527-31.
20. G-Nitro L-Arginine. Invest. Ophthalmol. Vis. Sci. 35, 3673-80.
21. Mann, R. M., Riva, C. E., Stone, R. A., Barnes, G. E. and Cranstoun, S. (1995). Nitric oxide and choroidal blood flow regulation. Invest. Ophthalmol. Vis. Sci. 36, 925-30.
22. 2+-dependently converts L-arginine into an activator of soluble guanylylcyclase. Biochem. Biophys. Res. Commun. 164, 678-85.
23. Meyer, P., Flammer, J., Lüscher, T. F. (1993a). Endothelium dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest. Ophthalmol. Vis. Sci. 34, 3614-21.
24. Meyer, P., Flammer, J. and Lüscher, T. F. (1993b). Local anesthetic drugs reduce endothelium-dependent relaxations of porcine ciliary arteries. Invest. Ophthalmol. Vis. Sci. 34, 2730-6.
25. Palmer, R. M. J., Rees, D. D., Ashton, D. S. and Moncada, S. (1988). L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153, 1251-6.
26. Palmer, R. M. J. and Moncada, S. (1989). A novel citrulline forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158, 348-52.
27. Rees, D. D., Palmer, M. J. and Moncada, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. PNAS 86, 3375-8.
28. Rees, D. D., Palmer, M. J., Schulz, R., Hodson, H. F. and Moncada, S. (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101, 746-52.
29. Schmetterer, L., Lexer, F., Unfried, C., Sattmann, H. and Percher, A. (1995). Topical measurement of fundus pulsations. Opt. Eng. 34, 711-6.
30. Schmetterer, L., Wolzt, M., Salomon, A., Rheinberger, A., Unfried, C., Zanaschka, G. and Percher, A. (1996a). The effect of isoproterenol, phenylephrine and sodium nitroprusside on fundus pulsations in healthy volunteers. Br. J. Ophthalmol. 80, 217-23.
31. Schmetterer, L., Strenn, K., Findl, O., Breiteneder, H., Graselli, U., Agneter, E., Eichler, H. G. and Wolzt, M. (1996b). Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Clin. Pharmacol. Ther. In press.
32. Stamler, J. S., Loh, E., Roddy, M., Currie, K. E. and Creager, M. A. (1994). Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89, 2035-40.
33. Tilton, R. G., Chang, K., Corbett, J. A., Misko, T. P., Currie, M. G., Bora, N. S., Kaplan, H. J. and Williamson, J. R. (1994). Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest. Ophthalmol. Vis. Sci. 35, 3278-88.
34. Whittle, B. J. R., Lopez-Belmonte, J. and Rees, D. D. (1989). Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br. J. Pharmacol. 98, 646-52.
35. Yoo, K., Tschudi, M. and Lüscher, T. P. (1991). Fndothelium-dependent regulation of vascular tone on the porcine ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 32, 1791-8.